Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated Tablet

NCT05082662 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-steroidal Anti-inflammatory (NSAID)
Analgesic
Antipyretic

Interventions

DRUG: Diclofenac Potassium coated tablet (50 mg Diclofenac Potassium)
DRUG: Cataflam® 50 coated tablet

Sponsor

Humanis Saglık Anonim Sirketi